These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 19939228

  • 1. MCI patients declining and not-declining at mid-term follow-up: FDG-PET findings.
    Pagani M, Dessi B, Morbelli S, Brugnolo A, Salmaso D, Piccini A, Mazzei D, Villavecchia G, Larsson SA, Rodriguez G, Nobili F.
    Curr Alzheimer Res; 2010 Jun; 7(4):287-94. PubMed ID: 19939228
    [Abstract] [Full Text] [Related]

  • 2. Unawareness of memory deficit in amnestic MCI: FDG-PET findings.
    Nobili F, Mazzei D, Dessi B, Morbelli S, Brugnolo A, Barbieri P, Girtler N, Sambuceti G, Rodriguez G, Pagani M.
    J Alzheimers Dis; 2010 Jun; 22(3):993-1003. PubMed ID: 20858977
    [Abstract] [Full Text] [Related]

  • 3. Mapping brain morphological and functional conversion patterns in amnestic MCI: a voxel-based MRI and FDG-PET study.
    Morbelli S, Piccardo A, Villavecchia G, Dessi B, Brugnolo A, Piccini A, Caroli A, Frisoni G, Rodriguez G, Nobili F.
    Eur J Nucl Med Mol Imaging; 2010 Jan; 37(1):36-45. PubMed ID: 19662411
    [Abstract] [Full Text] [Related]

  • 4. Metabolic correlates of reserve and resilience in MCI due to Alzheimer's Disease (AD).
    Bauckneht M, Chincarini A, Piva R, Arnaldi D, Girtler N, Massa F, Pardini M, Grazzini M, Efeturk H, Pagani M, Sambuceti G, Nobili F, Morbelli S.
    Alzheimers Res Ther; 2018 Apr 03; 10(1):35. PubMed ID: 29615111
    [Abstract] [Full Text] [Related]

  • 5. FDG-PET measurement is more accurate than neuropsychological assessments to predict global cognitive deterioration in patients with mild cognitive impairment.
    Chételat G, Eustache F, Viader F, De La Sayette V, Pélerin A, Mézenge F, Hannequin D, Dupuy B, Baron JC, Desgranges B.
    Neurocase; 2005 Feb 03; 11(1):14-25. PubMed ID: 15804920
    [Abstract] [Full Text] [Related]

  • 6. 18F-FDG PET diagnostic and prognostic patterns do not overlap in Alzheimer's disease (AD) patients at the mild cognitive impairment (MCI) stage.
    Morbelli S, Bauckneht M, Arnaldi D, Picco A, Pardini M, Brugnolo A, Buschiazzo A, Pagani M, Girtler N, Nieri A, Chincarini A, De Carli F, Sambuceti G, Nobili F.
    Eur J Nucl Med Mol Imaging; 2017 Nov 03; 44(12):2073-2083. PubMed ID: 28785843
    [Abstract] [Full Text] [Related]

  • 7. Differences in hippocampal metabolism between amnestic and non-amnestic MCI subjects: automated FDG-PET image analysis.
    Clerici F, Del Sole A, Chiti A, Maggiore L, Lecchi M, Pomati S, Mosconi L, Lucignani G, Mariani C.
    Q J Nucl Med Mol Imaging; 2009 Dec 03; 53(6):646-57. PubMed ID: 20016455
    [Abstract] [Full Text] [Related]

  • 8. Brain metabolic maps in Mild Cognitive Impairment predict heterogeneity of progression to dementia.
    Cerami C, Della Rosa PA, Magnani G, Santangelo R, Marcone A, Cappa SF, Perani D.
    Neuroimage Clin; 2015 Dec 03; 7():187-94. PubMed ID: 25610780
    [Abstract] [Full Text] [Related]

  • 9. Biomarker-Based Prediction of Progression to Dementia: F-18 FDG-PET in Amnestic MCI.
    Tripathi M, Tripathi M, Parida GK, Kumar R, Dwivedi S, Nehra A, Bal C.
    Neurol India; 2019 Dec 03; 67(5):1310-1317. PubMed ID: 31744965
    [Abstract] [Full Text] [Related]

  • 10. Principal component analysis of FDG PET in amnestic MCI.
    Nobili F, Salmaso D, Morbelli S, Girtler N, Piccardo A, Brugnolo A, Dessi B, Larsson SA, Rodriguez G, Pagani M.
    Eur J Nucl Med Mol Imaging; 2008 Dec 03; 35(12):2191-202. PubMed ID: 18648805
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Amnestic mild cognitive impairment in Parkinson's disease: a brain perfusion SPECT study.
    Nobili F, Abbruzzese G, Morbelli S, Marchese R, Girtler N, Dessi B, Brugnolo A, Canepa C, Drosos GC, Sambuceti G, Rodriguez G.
    Mov Disord; 2009 Feb 15; 24(3):414-21. PubMed ID: 19235928
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Comparing fludeoxyglucose F18-PET assessment of regional cerebral glucose metabolism and [11C]dihydrotetrabenazine-PET in evaluation of early dementia and mild cognitive impairment.
    Albin RL, Koeppe RA, Burke JF, Giordani B, Kilbourn MR, Gilman S, Frey KA.
    Arch Neurol; 2010 Apr 15; 67(4):440-6. PubMed ID: 20385910
    [Abstract] [Full Text] [Related]

  • 16. Detection of early amnestic mild cognitive impairment without significantly objective memory impairment: a case-controlled study.
    Murayama N, Iseki E, Fujishiro H, Yamamoto R, Ota K, Suzuki M, Nagashima K, Arai H, Sato K.
    Psychogeriatrics; 2010 Jun 15; 10(2):62-8. PubMed ID: 20738809
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Automated analysis of FDG PET as a tool for single-subject probabilistic prediction and detection of Alzheimer's disease dementia.
    Arbizu J, Prieto E, Martínez-Lage P, Martí-Climent JM, García-Granero M, Lamet I, Pastor P, Riverol M, Gómez-Isla MT, Peñuelas I, Richter JA, Weiner MW, Alzheimer's Disease Neuroimaging Initiative.
    Eur J Nucl Med Mol Imaging; 2013 Sep 15; 40(9):1394-405. PubMed ID: 23715905
    [Abstract] [Full Text] [Related]

  • 20. MCI conversion to dementia and the APOE genotype: a prediction study with FDG-PET.
    Mosconi L, Perani D, Sorbi S, Herholz K, Nacmias B, Holthoff V, Salmon E, Baron JC, De Cristofaro MT, Padovani A, Borroni B, Franceschi M, Bracco L, Pupi A.
    Neurology; 2004 Dec 28; 63(12):2332-40. PubMed ID: 15623696
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.